Comparison of asthma costs in patients starting fluticasone propionate compared to patients starting montelukast

Respiratory Medicine

Volumn 95, Issue 3, 2001, Pages 227-234

  Stempel, D A ^a   Mauskopf, J ^b   Mclaughlin, T ^c   Yazdani, C ^c   Stanford, R H ^d  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

^b RTI INTERNATIONAL   (United States)

^c Wolters Kluwer   (United States)

^d GLAXOSMITHKLINE   (United States)

Author keywords

Asthma; Cost; Inhaled corticosteroid; Leukotriene modifier

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; FLUTICASONE PROPIONATE; LEUKOTRIENE DERIVATIVE; METHYLXANTHINE; MONTELUKAST; SALMETEROL; STEROID; THEOPHYLLINE;

ADOLESCENT; ADULT; AGE; ARTICLE; ASTHMA; CHILD; CLINICAL OBSERVATION; COMORBIDITY; CONTROLLED STUDY; DRUG COST; FEMALE; GENDER; HEALTH CARE PLANNING; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; RETROSPECTIVE STUDY;

EID: 0034944210     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1053/rmed.2000.1027     Document Type: Article

References (21)

1. National trends in the morbidity and mortality of asthma in the US
2. Asthma mortality and hospitalization among children and young adults-United States, 1990-1993
3. An economic evaluation of asthma in the United States
4. A national estimate of the economic cost of asthma
5. Guidelines for the Diagnosis and Management of Asthma
6. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized controlled trial
7. Montelukast added to inhaled beclomethasone in treatment of asthma
8. Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma
9. Inhaled steroids and the risk of hospitalization for asthma
10. Outcomes and cost benefits associated with the introduction of inhaled corticosteroids therapy in a medicaid population of asthmatic patients
11. Explaining drug spending trends: Does perception match reality?
12. Increased use of inhaled corticosteroids and reduced hospitalizations in adult asthmatics: 11 years' experience in a Japanese hospital
13. First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthma
14. Use of pharmacy and medical claims database to document cost centers for 1993 annual asthma expenditures
15. Methods for analyzing health care utilization and costs
16. Flovent® (fluticasone propionate) inhalation aerosol. Package insert
17. Pediatric asthma deaths in Victoria: The mild are at risk
18. Low-dose inhaled corticosteroids and the prevention of death from asthma
19. Outcomes analysis in asthma